ClinVar Genomic variation as it relates to human health
NM_001378477.3(NYX):c.70_93del (p.Arg24_Ala31del)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_001378477.3(NYX):c.70_93del (p.Arg24_Ala31del)
Variation ID: 99841 Accession: VCV000099841.16
- Type and length
-
Deletion, 24 bp
- Location
-
Cytogenetic: Xp11.4 X: 41473529-41473552 (GRCh38) [ NCBI UCSC ] X: 41332782-41332805 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Apr 4, 2013 Sep 29, 2024 May 8, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_001378477.3:c.70_93del MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_001365406.2:p.Arg24_Ala31del inframe deletion NM_001378477.1:c.85_108del NM_022567.3:c.70_93del NP_072089.2:p.Arg24_Ala31del inframe deletion NC_000023.11:g.41473538_41473561del NC_000023.10:g.41332791_41332814del NG_009112.1:g.31079_31102del - Protein change
- -
- Other names
- -
- Canonical SPDI
- NC_000023.11:41473528:GCCTGCGCCCGCGCTTGTCCCGCCGCCTGCGCC:GCCTGCGCC
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
NYX | Sufficient evidence for dosage pathogenicity | No evidence available |
GRCh38 GRCh37 |
391 | 544 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic (5) |
criteria provided, multiple submitters, no conflicts
|
Jan 3, 2024 | RCV000086275.15 | |
Pathogenic (2) |
criteria provided, single submitter
|
May 8, 2024 | RCV001847656.2 | |
Pathogenic (1) |
criteria provided, single submitter
|
Jul 19, 2019 | RCV001073621.2 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(Jul 21, 2015)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Eurofins Ntd Llc (ga)
Accession: SCV000332913.4
First in ClinVar: Dec 06, 2016 Last updated: Dec 15, 2018 |
Number of individuals with the variant: 1
Sex: mixed
|
|
Pathogenic
(Mar 20, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV001982783.3
First in ClinVar: Oct 30, 2021 Last updated: Sep 29, 2024 |
Comment:
In-frame deletion of 8 amino acids in a non-repeat region; In silico analysis supports a deleterious effect on protein structure/function; This variant is associated with … (more)
In-frame deletion of 8 amino acids in a non-repeat region; In silico analysis supports a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 18617546, 11062471, 19578023) (less)
|
|
Pathogenic
(Jul 19, 2019)
|
criteria provided, single submitter
Method: clinical testing
|
Retinal dystrophy
Affected status: yes
Allele origin:
germline
|
Blueprint Genetics
Accession: SCV001239172.1
First in ClinVar: Apr 18, 2020 Last updated: Apr 18, 2020
Comment:
My Retina Tracker patient
|
|
|
Pathogenic
(Jan 03, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV001211381.5
First in ClinVar: Apr 15, 2020 Last updated: Feb 20, 2024 |
Comment:
This variant, c.85_108del, results in the deletion of 8 amino acid(s) of the NYX protein (p.Arg29_Ala36del), but otherwise preserves the integrity of the reading frame. … (more)
This variant, c.85_108del, results in the deletion of 8 amino acid(s) of the NYX protein (p.Arg29_Ala36del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs281865194, gnomAD 0.01%). This variant has been observed in individuals with congenital stationary night blindness (PMID: 11062471, 19578023). It has also been observed to segregate with disease in related individuals. This variant is also known as 85–108del24nt (RACPAACA29-36del). ClinVar contains an entry for this variant (Variation ID: 99841). For these reasons, this variant has been classified as Pathogenic. (less)
|
|
Pathogenic
(Oct 23, 2020)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
(X-linked recessive inheritance)
Affected status: yes
Allele origin:
germline
|
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen
Accession: SCV001447295.1
First in ClinVar: Nov 28, 2020 Last updated: Nov 28, 2020 |
Clinical Features:
Congenital stationary night blindness (present)
Sex: male
|
|
Pathogenic
(May 08, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Congenital stationary night blindness 1A
Affected status: yes
Allele origin:
germline
|
Clinical Genomics Laboratory, Washington University in St. Louis
Accession: SCV005045142.1
First in ClinVar: May 26, 2024 Last updated: May 26, 2024 |
Comment:
The NYX c.85_108del (p.Arg29_Ala36del) variant has been reported in 29 individuals in eight families with X-linked complete congenital stationary night blindness (Bech-Hansen NT et al., … (more)
The NYX c.85_108del (p.Arg29_Ala36del) variant has been reported in 29 individuals in eight families with X-linked complete congenital stationary night blindness (Bech-Hansen NT et al., PMID: 11062471; Zeitz C et al., PMID: 19578023). A genotype analysis of the X chromosomes with this deletion suggest that this is a common founder mutation. This variant is only observed on 1/19,558 alleles in the general population (gnomAD v.2.1.1), indicating it is not a common variant. This variant is predicted to cause a change in the length of the protein due to an in-frame deletion of eight amino acids in a non-repeat region. This variant has been reported in the ClinVar database as a germline pathogenic variant by six submitters. Based on available information and the ACMG/AMP guidelines for variant interpretation (Richards S et al., PMID: 25741868), this variant is classified as pathogenic. (less)
|
|
Pathogenic
(Nov 01, 2000)
|
no assertion criteria provided
Method: literature only
|
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1A
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000032407.1
First in ClinVar: Apr 04, 2013 Last updated: Apr 04, 2013 |
Comment on evidence:
In 7 families from the United States, Bech-Hansen et al. (2000) found that the same in-phase 24-bp deletion was associated with X-linked complete congenital stationary … (more)
In 7 families from the United States, Bech-Hansen et al. (2000) found that the same in-phase 24-bp deletion was associated with X-linked complete congenital stationary night blindness (310500). The deletion was predicted to result in the loss of the 8 amino acids RACPAACA from the N-terminal cysteine cluster of nyctalopin. A genotype analysis of the X chromosomes with this deletion suggested that these families share a common founder mutation. (less)
|
|
not provided
(-)
|
no classification provided
Method: not provided
|
not provided
Affected status: not provided
Allele origin:
not provided
|
Retina International
Accession: SCV000118421.1
First in ClinVar: Feb 20, 2014 Last updated: Feb 20, 2014
Comment:
http://phencode.bx.psu.edu/cgi-bin/phencode/phencode?build=hg19&id=RISN_NYX:c.85_108del
|
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Genotyping microarray for CSNB-associated genes. | Zeitz C | Investigative ophthalmology & visual science | 2009 | PMID: 19578023 |
Mutations in NYX, encoding the leucine-rich proteoglycan nyctalopin, cause X-linked complete congenital stationary night blindness. | Bech-Hansen NT | Nature genetics | 2000 | PMID: 11062471 |
http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=NYX | - | - | - | - |
Text-mined citations for rs281865194 ...
HelpRecord last updated Sep 29, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.